Stadler WM - Search Results

1

Randomized Phase III Trial of Gemcitabine and Cisplatin With Bevacizumab or Placebo in Patients With Advanced Urothelial Carcinoma: Results of CALGB 90601 (Alliance).

Rosenberg JE, Ballman KA, Halabi S, Atherton PJ, Mortazavi A, Sweeney C, Stadler WM, Teply BA, Picus J, Tagawa ST, Katragadda S, Vaena D, Misleh J, Hoimes C, Plimack ER, Flaig TW, Dreicer R, Bajorin D, Hahn O, Small EJ, Morris MJ. Rosenberg JE, et al. Among authors: stadler wm. J Clin Oncol. 2021 Aug 1;39(22):2486-2496. doi: 10.1200/JCO.21.00286. Epub 2021 May 14. J Clin Oncol. 2021. PMID: 33989025 Free PMC article. Clinical Trial.

2

Phase II study of single-agent gemcitabine in previously untreated patients with metastatic urothelial cancer.

Stadler WM, Kuzel T, Roth B, Raghavan D, Dorr FA. Stadler WM, et al. J Clin Oncol. 1997 Nov;15(11):3394-8. doi: 10.1200/JCO.1997.15.11.3394. J Clin Oncol. 1997. PMID: 9363871 Clinical Trial.

3

New chemotherapy regimens for advanced bladder cancer.

Fagbemi SO, Stadler WM. Fagbemi SO, et al. Among authors: stadler wm. Semin Urol Oncol. 1998 Feb;16(1):23-9. Semin Urol Oncol. 1998. PMID: 9508079 Review.

4

Multicenter phase II trial of interleukin-2, interferon-alpha, and 13-cis-retinoic acid in patients with metastatic renal-cell carcinoma.

Stadler WM, Kuzel T, Dumas M, Vogelzang NJ. Stadler WM, et al. J Clin Oncol. 1998 May;16(5):1820-5. doi: 10.1200/JCO.1998.16.5.1820. J Clin Oncol. 1998. PMID: 9586896 Clinical Trial.

5

Phase II trial of gemcitabine plus cisplatin in patients with metastatic urothelial cancer.

Kaufman D, Raghavan D, Carducci M, Levine EG, Murphy B, Aisner J, Kuzel T, Nicol S, Oh W, Stadler W. Kaufman D, et al. J Clin Oncol. 2000 May;18(9):1921-7. doi: 10.1200/JCO.2000.18.9.1921. J Clin Oncol. 2000. PMID: 10784633 Clinical Trial.

6

Phase II trial of weekly intravenous gemcitabine with continuous infusion fluorouracil in patients with metastatic renal cell cancer.

Rini BI, Vogelzang NJ, Dumas MC, Wade JL 3rd, Taber DA, Stadler WM. Rini BI, et al. Among authors: stadler wm. J Clin Oncol. 2000 Jun;18(12):2419-26. doi: 10.1200/JCO.2000.18.12.2419. J Clin Oncol. 2000. PMID: 10856102 Clinical Trial.

7

A phase II trial of weekly intravenous gemcitabine and cisplatin with continuous infusion fluorouracil in patients with metastatic renal cell carcinoma.

George CM, Vogelzang NJ, Rini BI, Geoffroy FJ, Kollipara P, Stadler WM. George CM, et al. Among authors: stadler wm. Ann Oncol. 2002 Jan;13(1):116-20. doi: 10.1093/annonc/mdf008. Ann Oncol. 2002. PMID: 11863091 Free article. Clinical Trial.

8

Gemcitabine doublets in advanced urothelial cancer.

Stadler WM. Stadler WM. Semin Oncol. 2002 Feb;29(1 Suppl 3):15-9. doi: 10.1053/sonc.2002.30752. Semin Oncol. 2002. PMID: 11894003 Review.

9

Allogeneic stem-cell transplantation of renal cell cancer after nonmyeloablative chemotherapy: feasibility, engraftment, and clinical results.

Rini BI, Zimmerman T, Stadler WM, Gajewski TF, Vogelzang NJ. Rini BI, et al. Among authors: stadler wm. J Clin Oncol. 2002 Apr 15;20(8):2017-24. doi: 10.1200/JCO.2002.08.068. J Clin Oncol. 2002. PMID: 11956260 Clinical Trial.

10

Randomized study of three different doses of suramin administered with a fixed dosing schedule in patients with advanced prostate cancer: results of intergroup 0159, cancer and leukemia group B 9480.

Small EJ, Halabi S, Ratain MJ, Rosner G, Stadler W, Palchak D, Marshall E, Rago R, Hars V, Wilding G, Petrylak D, Vogelzang NJ. Small EJ, et al. J Clin Oncol. 2002 Aug 15;20(16):3369-75. doi: 10.1200/JCO.2002.10.022. J Clin Oncol. 2002. PMID: 12177096 Clinical Trial.

Save citations to file

Email citations

Send citations to clipboard

Add to Collections

Add to My Bibliography

Create a file for external citation management software

Your saved search

Your RSS Feed

My NCBI Filters

Text availability

Article attribute

Article type

Publication date

338 results

Search Page